ETF Series Solutions Trust - Range Cancer Therapeutics ETF
CNCR - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.88B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.88 Billion |
|---|---|
| Enterprise Value | - |
| Annual dividend | $1.85 |
| Earnings per Share | $- |
| Beta | 0.96 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Bluemonte Large Cap Value ETF
CEO: None
The investment seeks to track the performance, before fees and expenses, of the EQM Brand Value Index (the "index"). Under normal circumstances, at least 80% of the fund's total assets (exclusive of any collateral held from securities le...